We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
-5.18%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$2.76B
AUM Growth
-$525M
Cap. Flow
-$439M
Cap. Flow %
-15.9%
Top 10 Hldgs %
38.29%
Holding
343
New
69
Increased
54
Reduced
100
Closed
111

Top Buys

Rank Stock Value
1
VRAY
ViewRay, Inc.
VRAY
+$17.9M
2
SLGC
SomaLogic, Inc. Class A Common Stock
SLGC
+$17.3M
3
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$14.1M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$14M
5
CUTR
Cutera, Inc.
CUTR
+$12.7M

Top Sells

Rank Stock Value
1
SEER icon
Seer Inc
SEER
+$24.7M
2
MAPS
WM TECHNOLOGY INC A
MAPS
+$23.4M
3
LIVN icon
LivaNova
LIVN
+$20.2M
4
GKOS icon
Glaukos
GKOS
+$17.5M
5
COO icon
Cooper Companies
COO
+$16.3M

Sector Composition

Rank Sector Weight
1 Healthcare 29.75%
2 Consumer Staples 0.58%
3 Financials 0.5%
4 Consumer Discretionary 0.42%
5 Industrials 0.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OMIC
176
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$1.05M 0.04%
+3,018
New +$1.17M
OBIO icon
177
Orchestra BioMed
OBIO
$266M
$1.04M 0.04%
103,526
-2,776
-3% -$27.4K
KOD icon
178
Kodiak Sciences
KOD
$2.72B
$1.03M 0.04%
+12,115
New +$1.23M
CCXI
179
DELISTED
ChemoCentryx, Inc.
CCXI
$1.02M 0.04%
+28,118
New +$987K
MDVL
180
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
$1M 0.04%
14,282
– –
GOSS icon
181
Gossamer Bio
GOSS
$86.8M
$989K 0.04%
87,429
-2,648
-3% -$31.5K
ARYE
182
DELISTED
ARYA Sciences Acquisition Corp V Class A Ordinary Shares
ARYE
$960K 0.03%
98,980
-1,020
-1% -$10K
DCPH
183
CALL
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$959K 0.03%
98,200
-1,500
-2% -$28.2K
CCCC icon
184
C4 Therapeutics
CCCC
$480M
$942K 0.03%
29,244
+9,244
+46% +$366K
VIR icon
185
Vir Biotechnology
VIR
$1.52B
$908K 0.03%
+21,685
New +$850K
TNGX icon
186
Tango Therapeutics
TNGX
$4.31B
$900K 0.03%
82,227
-2,535
-3% -$30.5K
OLMA icon
187
Olema Pharmaceuticals
OLMA
$913M
$874K 0.03%
+93,330
New +$1.93M
RDUS
188
DELISTED
Radius Health, Inc.
RDUS
$862K 0.03%
+124,607
New +$1.83M
ABOS icon
189
Acumen Pharmaceuticals
ABOS
$181M
$852K 0.03%
126,060
+51,060
+68% +$561K
KRYS icon
190
PUT
Krystal Biotech
KRYS
$9.85B
$846K 0.03%
12,100
-200
-2% -$11.6K
SPKBU
191
DELISTED
Silver Spike Acquisition Corp II Units
SPKBU
$771K 0.03%
77,505
– –
OYST
192
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$751K 0.03%
+41,130
New +$522K
NAUT icon
193
Nautilus Biotechnolgy
NAUT
$114M
$745K 0.03%
143,798
-4,502
-3% -$24.1K
NGM
194
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$745K 0.03%
42,069
-1,248
-3% -$23.9K
MRTX
195
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$715K 0.03%
4,872
-10,128
-68% -$1.57M
ACRS icon
196
Aclaris Therapeutics
ACRS
$860M
$702K 0.03%
+48,266
New +$731K
ENVB icon
197
Enveric Biosciences
ENVB
$6.24M
$690K 0.03%
+82
New +$1.15M
SLGCW
198
DELISTED
SomaLogic, Inc. Warrant
SLGCW
$683K 0.02%
204,401
-3,126
-2% -$11.9K
AMRN
199
Amarin Corp
AMRN
$297M
$664K 0.02%
+9,857
New +$816K
IMCR icon
200
Immunocore
IMCR
$1.77B
$653K 0.02%
19,071
-30,929
-62% -$1.12M
6 7
8
9 10

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q4 2021 Portfolio in Review

As of Q4 2021, Pura Vida Investments held 343 positions worth $2.76B, down 16% from $3.29B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Pura Vida Investments withdrew a net $439M in Q4 2021, closing 111 positions and reducing 100 holdings. Its most notable exit was Seer Inc, an estimated $24.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 33% a quarter earlier, followed by Consumer Staples and Financials.

Against the trend, Pura Vida Investments opened a new position in BioMarin Pharmaceuticals worth $15M.

  • Pura Vida Investments's largest Q4 2021 buy was BioMarin Pharmaceuticals: 170,210 shares worth $15M.
  • Pura Vida Investments added most to ViewRay, Inc. in Q4 2021, an estimated $17.9M increase.
  • Pura Vida Investments's biggest Q4 2021 reduction was LivaNova, cutting an estimated $20.2M.
  • Pura Vida Investments fully exited Seer Inc in Q4 2021, selling an estimated $24.7M.
  • Pura Vida Investments's ten largest holdings make up 38% of its $2.76B portfolio in Q4 2021.
  • Pura Vida Investments opened 69 new positions and closed 111 in Q4 2021.
  • Pura Vida Investments's portfolio value fell 16% quarter-over-quarter to $2.76B.

Based on Pura Vida Investments's 13F filing for Q4 2021, filed 14 Feb 2022.